Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000423878 | SCV000517574 | benign | not specified | 2015-12-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001521290 | SCV001730604 | benign | Combined oxidative phosphorylation defect type 17 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001521290 | SCV001875998 | benign | Combined oxidative phosphorylation defect type 17 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316536 | SCV004017433 | benign | Prostate cancer, hereditary, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676442 | SCV000802223 | benign | not provided | 2016-02-15 | no assertion criteria provided | clinical testing |